Mangoceuticals (MGRX) Receivables - Other (2025 - 2026)

Mangoceuticals (MGRX) reported Receivables - Other of $20056.0 for Q1 2026, little changed sequentially from $20056.0 in Q4 2025.

Mangoceuticals (MGRX) Receivables - Other (2025 - 2026) Analysis & Trends

Mangoceuticals (MGRX) has 2 years of Receivables - Other data on file, last reported at $20056.0 in Q1 2026.

For the quarter ending Q1 2026, Receivables - Other changed N/A year-over-year to $20056.0; the trailing twelve-month figure through Mar 2026 stood at $20056.0 (changed N/A YoY), and the FY2025 full-year result was $20056.0, changed N/A from the prior year.
Receivables - Other held at $20056.0 in Q1 2026, from $20056.0 in the prior quarter.
In the past five years, Receivables - Other ranged from a high of $20056.0 in Q4 2025 to a low of $20056.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	31.81 Bn	24.49 Bn	662.02 Mn
2	BrightSpring Health Services	14.76 Bn	13.86 Bn	482.22 Mn
3	Healthequity	8.36 Bn	8.10 Bn	256.31 Mn
4	Hinge Health	5.91 Bn	5.60 Bn	154.23 Mn
5	10x Genomics	5.89 Bn	5.35 Bn	106.18 Mn
6	MiniMed	4.45 Bn	4.16 Bn	480.00 Mn
7	Waystar Holding	4.41 Bn	4.35 Bn	216.84 Mn
8	Doximity	3.93 Bn	3.18 Bn	125.97 Mn
9	Privia Health	3.10 Bn	2.68 Bn	-
10	Mangoceuticals	9.39 Mn	9.20 Mn	29,001.00

Download Data